Showing results (321-330 of 432) with videos related to

Sort By:
Pageof 44
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2010
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT studyFrank A Post, Graeme J Moyle, Hans Jürgen Stellbrink, et al.
Open Forum Infectious Diseases|January 15, 2024
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched AnalysisDaniel K Nomah, Yesika Díaz, Andreu Bruguera, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|May 22, 2012
Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident casesInés Suárez-García, Inmaculada Jarrín, José Antonio Iribarren, et al.
European Journal of Medical Research|April 5, 2024
Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phaseJoaquim Peraire, Graciano García-Pardo, Silvia Chafino, et al.
Communications Medicine|October 23, 2025
Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIVSilvia Chafino, Laura Tarancon-Diez, Jara Hurtado-Gallego, et al.
AIDS Care|August 18, 2025
Where did they go? Describing and reengaging people with HIV lost to follow-up in the PISCIS Cohort StudyJorge Palacio-Vieira, Sergio Moreno-Fornés, Yesika Díaz, et al.
European Journal of Pharmacology|July 27, 2025
Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIVTania Quesada-López, Alberto Mestres-Arenas, Pere Domingo, et al.
HIV Clinical Trials|April 19, 2012
Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patientsJuan Macías, Karin Neukam, Josep Mallolas, et al.
The Journal of Infection|December 6, 2011
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosisJuan A Pineda, Karin Neukam, Josep Mallolas, et al.
Current HIV Research|July 16, 2009
The changing face of HIV/AIDS in treated patientsJosep M Llibre, Vicenç Falco, Cristina Tural, et al.
Pageof 44